Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: Mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy

• Autores: Andrew P. Levy
• Localización: Pharmacology & Therapeutics: The journal of the International Encyclopedia of Pharmacology and Therapeutics, ISSN 0163-7258, Vol. 112, Nº. 2, 2006, págs. 501-512
• Idioma: inglés
• Texto completo no disponible (Saber más ...)